18:40:11 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Sept. 19, 2014

2014-09-19 19:03 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 10.74 points to 955.06 Friday, ending the week down 32.87 points and falling to a seven-month low. Even though the TSX-V has had a rough four years, there are promoters in the shell sector who have managed to survive. Some have even thrived. One of them is Bay Street's Pat DiCapo, who has filed a preliminary prospectus for his third capital pool shell, POCML 3 Inc. Dundee Securities Ltd. is handling the shell's $300,000 initial public offering of two million shares at 15 cents. It will be the broker's first shell this year.

POCML 3 has five million shares in escrow that sold at 7.5 cents. Mr. DiCapo, 39, is a founder and director of the shell, and the largest shareholder with four million escrow shares. He is a lawyer who owns PowerOne Capital Markets Ltd., a Toronto firm that finances and advises emerging companies. POCML 3 is Mr. DiCapo's third capital pool shell, and considering the success of his first two, Dundee will have no trouble rounding up the required 200 investors for the $300,000 IPO. Mr. DiCapo's first capital pool shell, POCML 1 Inc., arrived on the TSX-V in July, 2011, after selling IPO shares at 20 cents. In October, 2012, it acquired a Quebec graphite explorer and changed its name to Mason Graphite Inc. (LLG: $0.72). The stock opened at 90 cents, rose to $1 three months later, and since then has traded between 25.5 cents and $1.08. All IPO shareholders have had an opportunity to sell and earn up to five times their initial investment, making POCML 1 a success. Mr. DiCapo's second capital pool shell, POCML 2 Inc., went public at 15 cents in May, 2013. Last month, it rolled back 1:2 and launched Marc Wayne's licensed medical marijuana producer, Bedrocan Cannabis Corp. (BED: $0.90), as its qualifying transaction. Bedrocan opened at $1.25, and since then has traded between 86 cents and $1.45. IPO buyers were rolled back 1:2 and could have sold today for a triple, making it two successes for Mr. DiCapo and no failures. Next week, investors in Toronto can attend the Cambridge House Canadian Investor Conference if they wish to see Mr. DiCapo, who will sit down for a 30-minute question-and-answer session with Tommy Humphreys of CEO.ca as moderator.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed